SLC35B2 antibody (C-Term)
Quick Overview for SLC35B2 antibody (C-Term) (ABIN6258665)
Target
See all SLC35B2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Specificity
- SLC35B2 Antibody detects endogenous levels of total SLC35B2.
-
Predicted Reactivity
- Pig,Bovine,Horse,Sheep,Dog
-
Purification
- The antiserum was purified by peptide affinity chromatography using SulfoLinkTM Coupling Resin (Thermo Fisher Scientific).
-
Immunogen
- A synthesized peptide derived from human SLC35B2, corresponding to a region within C-terminal amino acids.
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB 1:500-1:2000, IHC 1:50-1:200, ELISA(peptide) 1:20000-1:40000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Expiry Date
- 12 months
-
-
- SLC35B2 (Solute Carrier Family 35, Member B2 (SLC35B2))
-
Alternative Name
- SLC35B2
-
Background
-
Description: Mediates the transport of adenosine 3'-phospho 5'-phosphosulfate (PAPS), from cytosol into Golgi. PAPS is a universal sulfuryl donor for sulfation events that take place in the Golgi. May indirectly participate in activation of the NF-kappa-B and MAPK pathways.
Gene: SLC35B2
-
Molecular Weight
- 48 kDa
-
Gene ID
- 347734
-
UniProt
- Q8TB61
-
Pathways
- Glycosaminoglycan Metabolic Process, Ribonucleoside Biosynthetic Process
Target
-